Benzoates - an Obesogenic Endocrine Disrupting Chemical
Benzoic Acid in Beverages: Establishing a Link Between Urinary Metabolites, Metabolic Dysregulation and Weight Loss Failure
1 other identifier
interventional
20
1 country
1
Brief Summary
The benzoic acid derivatives sodium and potassium benzoate are preservatives that are commonly added to food and beverages to inhibit microbial growth and prevent spoilage. In the US the major source of benzoate intake is beverages. Studies have shown that piglets or chicks fed low levels of benzoic acid have greater feed efficiency and gain more weight than control fed animals. It has also been shown that benzoic acid inhibits the release of a key metabolic hormone, leptin, from isolated adipocytes (fat cells). Inadequate leptin levels result in increased appetite, decreased metabolic rate, weight gain, insulin resistance and increased diabetes risk. The primary aim of the proposed research is to directly determine if benzoate consumption in human volunteers results in lower levels of leptin, decreased metabolic rate and increased insulin resistance. If so this would implicate benzoic acid as an obesogen and would help inform more effective approaches to obesity prevention and treatment. A secondary aim of the study is to establish a connection between benzoate exposure and biomarkers in urine that can be used to help treat obese patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable obesity
Started Jul 2017
Typical duration for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 13, 2017
CompletedFirst Posted
Study publicly available on registry
June 19, 2017
CompletedStudy Start
First participant enrolled
July 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2021
CompletedMarch 24, 2023
March 1, 2023
3.7 years
June 13, 2017
March 23, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Metabolic rate
Metabolic rate as measured by indirect calorimetry
measured following 1 week dietary exposure to benzoic acid.
Secondary Outcomes (1)
Leptin levels
measured following 1 week dietary exposure to benzoic acid
Study Arms (1)
Benzoic acid washout and exposure
EXPERIMENTALAll subjects will be in this arm which employs a pre-post exposure design. Subjects will undergo a 2 week washout period where they avoid consumption of benzoate containing beverages. Then there is a 1 week exposure period comprising daily consumption of benzoate containing beverages to result in up to 5 mg/kg per day benzoic acid intake.
Interventions
Eligibility Criteria
You may qualify if:
- Young adult (18-30 yrs)
- Healthy non-smoker
- Either overweight (BMI \>25 but \<30) or obese (BMI \>30)
- Has or can obtain transportation to study site
- Able to provide written consent in English
You may not qualify if:
- Metabolic disease
- Diabetes mellitus
- Hypothyroidism
- Use of medication that may influence metabolism
- Anti-hyperglycemic agents
- Thyroid hormone
- Stimulants for ADD/ADHD
- Atypical anti-psychotics
- Weight loss medications
- Benzoate sensitivity
- Known pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Brody School of Medicine at East Carolina University
Greenville, North Carolina, 27834, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Pediatrics
Study Record Dates
First Submitted
June 13, 2017
First Posted
June 19, 2017
Study Start
July 1, 2017
Primary Completion
March 1, 2021
Study Completion
April 1, 2021
Last Updated
March 24, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share